Alimentary Pharmacology & Therapeutics

Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease
pp. 807-822(16)
Authors: Lewis, S. J.; Freedman, A. R.

One-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori
pp. 823-837(15)
Authors: Pipkin, G. A.; Williamson, R.; Wood, J. R.

Idiopathic bile acid malabsorption: qualitative and quantitative clinical features and response to cholestyramine
pp. 839-844(6)
Authors: Sinha, L.; Liston, R.; Testa, H. J.; Moriarty, K. J.

Ferric trimaltol corrects iron deficiency anaemia in patients intolerant of iron
pp. 845-848(4)
Authors: Harvey, R. S. J.; Reffitt, D. M.; Doig, L. A.; Meenan, J.; Ellis, R. D.; Thompson, R. P. H.; Powell, J. J.

Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome
pp. 849-855(7)
Authors: Delvaux, M.; Louvel, D.; Mamet, J.-P.; Campos-Oriola, R.; Frexinos, J.

Helicobacter pylori-positive peptic ulcer patients do not adapt to aspirin
pp. 857-864(8)
Authors: Konturek, J. W.; Konturek, S. J.; Stachura, J.; Domschke, W.

Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis
pp. 865-872(8)
Authors: Dettmer, A.; Vogt, R.; Sielaff, F.; Lühmann, R.; Schneider, A.; Fischer, R.

H₂-antagonist maintenance therapy versus Helicobacter pylori eradication in patients with chronic duodenal ulcer disease: a prospective study
pp. 873-880(8)
Authors: Prach, A. T.; Malek, M.; Tavakoli, M.; Hopwood, D.; Senior, B. W.; Murray, F. E.

Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin
pp. 881-885(5)
Authors: Louw, J. A.; Rensburg, C. J. Van; Moola, S.; Kotze, D.; Marks, I. N.

Low rate of emergence of clarithromycin-resistant Helicobacter pylori with amoxycillin co-therapy
pp. 887-892(6)
Authors: Laine, L.; Suchower, L.; Frantz, J.; Connors, A.; Neil, G.

Continuous treatment with omeprazole 20 mg daily for up to 6 years in Barrett's oesophagus
pp. 893-897(5)
Authors: Cooper, B. T.; Neumann, C. S.; Cox, M. A.; Iqbal, T. H.

The effect of healing oesophagitis on oesophageal motor function as determined by oesophageal scintigraphy and ambulatory oesophageal motility/pH monitoring
pp. 899-907(9)
Authors: Dougall, N. I. M C; Mooney, R. B.; Ferguson, W. R.; Collins, J. S. A.; Mcfarland, R. J.; Love, A. H. G.

On-demand treatment of gastro-oesophageal reflux symptoms: a comparison of ranitidine 75 mg with cimetidine 200 mg or placebo
pp. 909-917(9)
Authors: Galmiche, J. P.; Shi, G.; Simon, B.; Casset-Semanaz, F.; Slama, A.

Estimating the cost of lost productivity in dyspepsia
pp. 919-923(5)
Authors: Severens, J. L.; Laheij, R. J. F.; Jansen, J. B. M. J.; Lisdonk, E. H. Van Der; Verbeek, A. L. M.

Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine
pp. 925-934(10)
Authors: Axelsson, L.-G.; Landström, E.; Bylund-Fellenius, A.-C.

Erratum
pp. 935-935(1)